Superoxide Dismutase - Administration & dosage
Research News and Information

Monday, November 23, 2009

Protective effect of lecithinized SOD on reactive oxygen species-induced xerostomia.

30 Aug 2009 Reactive oxygen species (ROS) are believed to be involved in radiation-induced xerostomia, and the application of antioxidants may be a promising method for treating patients suffering from salivary gland dysfunction. In this study, we examined the ... Read more...

Preventive effect of a melon extract rich in superoxide scavenging activity on abdominal and liver fat and adipokine imbalance in high-fat-fed hamsters.

20 Jul 2009 Studies showed that dietary antioxidants could be a therapy against obesity that is associated with a state of oxidative stress. Thus, this paper investigates whether a dietary ingredient, a melon juice extract rich in superoxide dismutase, would ... Read more...

Oral supplementation with melon superoxide dismutase extract promotes antioxidant defences in the brain and prevents stress-induced impairment of spatial memory.

6 Jun 2009 The purpose of this study was to investigate the effect of antioxidant ingestion on stress-induced impairment of cognitive memory. Male C57BL/6 mice were divided into four groups as follows: (1) control mice (C mice) fed in a normal cage without ... Read more...

Latest indexed articles for 'Superoxide Dismutase - Administration & dosage'

These are the very latest articles for this heading:

• Protective effect of lecithinized SOD on reactive oxygen species-induced xerostomia. 30 Aug 2009
• Preventive effect of a melon extract rich in superoxide scavenging activity on abdominal and liver fat and adipokine imbalance in high-fat-fed hamsters. 20 Jul 2009
• Oral supplementation with melon superoxide dismutase extract promotes antioxidant defences in the brain and prevents stress-induced impairment of spatial memory. 6 Jun 2009
• Comparison of the efficacy of narrow band ultraviolet B and narrow band ultraviolet B plus topical catalase-superoxide dismutase treatment in vitiligo patients. 23 May 2009
• Anti-inflammatory activity of superoxide dismutase obtained from Debaryomyces hansenii on type II collagen induced arthritis in rats. 29 Apr 2009
• Augmented inhibitory effect of superoxide dismutase on superoxide anion release from macrophages by chemical modification with polysaccharide and attenuation effects on radiation-induced inflammatory cytokine expression in vitro. 30 Mar 2009
• Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury. 3 Jan 2009
• The basis of topical superoxide dismutase antipruritic activity. 30 Dec 2008
• Long-term hearing loss in gerbils with bacterial meningitis treated with superoxide dismutase. 29 Nov 2008
• Potential of 3,4-dihydroxy-phenyl lactic acid for ameliorating ischemia-reperfusion-induced microvascular disturbance in rat mesentery. 11 Nov 2008
• Effect of local application of superoxide dismutase on dielectric parameters of cooled skin in rats. 30 Oct 2008
• A recombinant MnSOD is radioprotective for normal cells and radiosensitizing for tumor cells. 23 Oct 2008
• Loss of extracellular superoxide dismutase leads to acute lung damage in the presence of ambient air: a potential mechanism underlying adult respiratory distress syndrome. 9 Sep 2008
• Cerebral vascular responsiveness after experimental traumatic brain injury: the beneficial effects of delayed hypothermia combined with superoxide dismutase administration. 30 Aug 2008
• Increased biological half-life of aerosolized liposomal recombinant human Cu/Zn superoxide dismutase in pigs. 30 Aug 2008
• Systemic administration of PEP-1-SOD1 fusion protein improves functional recovery by inhibition of neuronal cell death after spinal cord injury. 25 Jul 2008
• A double-blind, randomized trial of 0.05% betamethasone vs. topical catalase/dismutase superoxide in vitiligo. 23 Jun 2008
• Superoxide dismutase-loaded PLGA nanoparticles protect cultured human neurons under oxidative stress. 27 May 2008
• Effects of an oral superoxide dismutase enzyme supplementation on indices of oxidative stress, proviral load, and CD4:CD8 ratios in asymptomatic FIV-infected cats. 31 Mar 2008
• Superoxidase dismutase (SOD) topical use in oncologic patients: treatment of acute cutaneous toxicity secondary to radiotherapy. 28 Feb 2008

See a longer list of these articles.

Technical information about 'Superoxide Dismutase'

Definition: An oxidoreductase that catalyzes the reaction between superoxide anions and hydrogen to yield molecular oxygen and hydrogen peroxide. The enzyme protects the cell against dangerous levels of superoxide. EC 1.15.1.1.

Chemical name: Superoxide:superoxide oxidoreductase

Registry Number: EC 1.15.1.1

Descriptor UI: D013482

Alternative terms: Superoxide Dismutase; Dismutase, Superoxide; Erythrocuprein; Hemocuprein; Ag-Zn Superoxide Dismutase; Ag Zn Superoxide Dismutase; Dismutase, Ag-Zn Superoxide; Superoxide Dismutase, Ag-Zn; Cu-Zn Superoxide Dismutase; Cu Zn Superoxide Dismutase; Dismutase, Cu-Zn Superoxide; Superoxide Dismutase, Cu-Zn; Cuprozinc Superoxide Dismutase; Dismutase, Cuprozinc Superoxide; Superoxide Dismutase, Cuprozinc; Mn-Superoxide Dismutase; Dismutase, Mn-Superoxide; Mn Superoxide Dismutase; Manganese Superoxide Dismutase; Dismutase, Manganese Superoxide; Superoxide Dismutase, Manganese; Mn-SOD; Mn SOD; Cobalt Superoxide Dismutase; Dismutase, Cobalt Superoxide; Superoxide Dismutase, Cobalt; Cu-Superoxide Dismutase; Cu Superoxide Dismutase; Dismutase, Cu-Superoxide; Fe-Zn Superoxide Dismutase; Dismutase, Fe-Zn Superoxide; Fe Zn Superoxide Dismutase; Superoxide Dismutase, Fe-Zn; Iron Superoxide Dismutase; Dismutase, Iron Superoxide; Superoxide Dismutase, Iron; Fe-Superoxide Dismutase; Dismutase, Fe-Superoxide; Fe Superoxide Dismutase;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications;

Pharmacological Action: Free Radical Scavengers;

Tree Number: D08.811.682.881;

History Note: 74(73)